01/08/2025
6:45 AM | Profound Medical (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
01/06/2025
7:30 AM | Profound Medical (Filer)
| Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
12/06/2024
4:18 PM | Profound Medical (Filer)
| Form SUPPL | |
12/06/2024
4:19 PM | Profound Medical (Filer)
| Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
12/06/2024
2:10 PM | Profound Medical (Filer)
| Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
12/05/2024
4:16 PM | Profound Medical (Filer)
| Form SUPPL | |
12/05/2024
4:21 PM | Profound Medical (Filer)
| Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
12/05/2024
4:01 PM | Profound Medical (Filer)
| Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
12/02/2024
6:45 AM | Profound Medical (Filer)
| Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
11/26/2024
7:00 AM | Profound Medical (Filer)
| Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
11/14/2024
3:27 PM | GAGNON SECURITIES LLC (Filed by)
Profound Medical (Subject)
| Form SC 13G/A | |
|
11/12/2024
12:52 PM | Goodman Abbey (Reporting)
Profound Medical (Subject)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
11/04/2024
6:15 AM | Profound Medical (Filer)
| Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
10/17/2024
3:45 PM | Profound Medical (Filer)
| Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
10/16/2024
3:30 PM | Profound Medical (Filer)
| Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
10/11/2024
8:42 AM | LETKO, BROSSEAU & ASSOCIATES INC (Filed by)
Profound Medical (Subject)
| Form SCHEDULE 13G/A | |
09/23/2024
3:42 PM | Jordan-Cornet Helen (Reporting)
Profound Medical (Subject)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
09/16/2024
7:15 AM | Profound Medical (Filer)
| Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
09/12/2024
5:02 AM | Profound Medical (Filer)
| Form S-8
Registration statement under Securities Act of 1933 to be offered to employees pursuant to certain plans | |
09/04/2024
4:02 PM | Profound Medical (Filer)
| Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
08/30/2024
11:15 AM | Jordan-Cornet Helen (Reporting)
Profound Medical (Subject)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
08/27/2024
12:31 PM | Jordan-Cornet Helen (Reporting)
Profound Medical (Subject)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
08/05/2024
6:50 AM | BDC CAPITAL INC. (Filed by)
Profound Medical (Subject)
| Form SC 13G/A | |
07/18/2024
3:45 PM | Profound Medical (Filer)
| Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
07/15/2024
11:15 PM | Profound Medical (Filer)
| Form EFFECT | |
07/10/2024
5:37 PM | Profound Medical (Filer)
| Form F-10/A | |
06/14/2024
4:23 PM | Profound Medical (Subject)
| Form F-X
Appointment of agent for service of process and undertaking | |
06/03/2024
3:30 PM | Profound Medical (Filer)
| Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
05/14/2024
8:30 AM | Profound Medical (Filer)
| Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
05/06/2024
3:30 PM | Profound Medical (Filer)
| Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
04/22/2024
3:20 PM | Profound Medical (Filer)
| Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
04/09/2024
6:55 AM | Profound Medical (Filer)
| Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
03/26/2024
11:31 AM | Goodman Abbey (Reporting)
Profound Medical (Subject)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
03/07/2024
3:42 PM | Profound Medical (Filer)
| Form 40-F
Registration statement pursuant to Section 12 or annual report pursuant to Section 13(a) or 15(d) | |
02/27/2024
7:00 AM | Profound Medical (Filer)
| Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
02/15/2024
3:45 PM | Profound Medical (Filer)
| Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
02/12/2024
1:37 PM | LETKO, BROSSEAU & ASSOCIATES INC (Filed by)
Profound Medical (Subject)
| Form SC 13G/A | |
02/09/2024
6:59 AM | FIL Ltd (Filed by)
Profound Medical (Subject)
| Form SC 13G/A | |
